Cancer Research Clinical Trials in Switzerland

Oncovara Pharmaceuticals Ltd

Oncovara Pharmaceuticals Ltd is a pioneering biotechnology company focused on the discovery and development of next-generation cancer therapies. Our mission is to transform the treatment landscape for oncology patients through innovative, targeted solutions grounded in rigorous science and patient-centric design.

Building on years of pre-clinical research and breakthrough discoveries in cancer fighting molecules and immune modulation, Oncovara is preparing to commence first-in-human clinical trials in Switzerland in 2026. These trials represent a critical step toward validating our lead therapeutic candidate and advancing it toward market readiness.

We are currently raising capital to fund our clinical programme, including the regulatory and operational infrastructure required to initiate Phase I studies. In parallel, Oncovara is strengthening its intellectual property portfolio, actively pursuing patent filings and registrations to protect our proprietary technologies and novel therapeutic approaches.

As we move toward clinical readiness, we are also mobilising potential patient cohorts and expanding our collaborations with research institutions, clinical investigators, and regulatory bodies to ensure the success of our upcoming trials.

With a strong scientific foundation, a dedicated leadership team, and a clear roadmap to clinical validation, Oncovara Pharmaceuticals Ltd is positioned to become a key innovator in the global fight against cancer.

www.Oncovara.com